ArticleOncology letters2014

Prognostic significance of C-reactive protein in patients with intermediate-risk metastatic renal cell carcinoma treated with molecular targeted therapy.

Jun Teishima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.